Zobrazeno 1 - 10
of 342
pro vyhledávání: '"Treuer T"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1019-1025 (2017)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Ai Koyanagi,4 Jaume Aguado,4 Susanne Kraemer,5 Josep Maria Haro4 1Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly and Company, Windlesham, Surrey, UK; 2Global Patient Outcomes and
Externí odkaz:
https://doaj.org/article/ed0c4aee490640f18b7640290271d3cb
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2927-2939 (2016)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Maria Victoria Moneta,4 Josep Maria Haro4 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Eli Lilly and Company, Neuroscience Research, Budap
Externí odkaz:
https://doaj.org/article/31853c122c8e4fdf878927e63784e87a
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1061-1083 (2016)
Tamás Treuer,1 Luis Méndez,2 William Montgomery,3 Shenghu Wu4 1Neuroscience Research, Eli Lilly and Company, Budapest, Hungary; 2Eli Lilly de Mexico, Mexico City, Mexico; 3Global Patient Outcomes and Real World Evidence, Eli Lilly Australia Pty Ltd
Externí odkaz:
https://doaj.org/article/0c83fb1ec3ff4d678fd633e08091cc78
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 177-183 (2015)
William Montgomery,1 Zbigniew Kadziola,2 Wenye Ye,3 Hai Bo Xue,4 Li Liu,4 Tamás Treuer5 1Global Patient Outcomes and Real World Evidence, Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 2Real World Analytics Capabilities, Eli Lilly GmbH, Vie
Externí odkaz:
https://doaj.org/article/9f31026778314d5795bd07a66b07871b
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1287-1296 (2014)
William Montgomery,1 Tamas Treuer,2 Wenyu Ye,3 Hai Bo Xue,4 Sheng Hu Wu,4 Li Liu,4 Zbigniew Kadziola,5 Michael D Stensland,6 Haya Ascher-Svanum7 1Global Health Outcomes Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 2Neuroscience Research, E
Externí odkaz:
https://doaj.org/article/5605d906b7e540bd83b90fbc0a58c7ff
Publikováno v:
Patient Preference and Adherence, Vol 2013, Iss default, Pp 987-995 (2013)
Jihyung Hong,1 Diego Novick,1 Tamás Treuer,2 William Montgomery,3 Virginia S Haynes,4 Shenghu Wu,5 Josep Maria Haro61Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly and Company, Neuroscience Research, Budapest, Hungary; 3Eli Lilly Australi
Externí odkaz:
https://doaj.org/article/368b398e69674e489cbcad1e75df8bc5
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2013, Iss default, Pp 407-418 (2013)
William Montgomery,1 Li Liu,2 Michael D Stensland,5 Hai Bo Xue,2 Tamas Treuer,4 Haya Ascher-Svanum31Eli Lilly and Company, Sydney, NSW, Australia; 2Lilly Suzhou Pharmaceutical Company, Ltd, Shanghai, People's Republic of China; 3Eli Lilly and Company
Externí odkaz:
https://doaj.org/article/4cff3c471c504abbb336ee608f5b73c3
Publikováno v:
Patient Preference and Adherence, Vol 2012, Iss default, Pp 109-125 (2012)
William Montgomery1, Tamas Treuer2, Jamie Karagianis3, Haya Ascher-Svanum4, Gavan Harrison51Global Health Outcomes, Eli Lilly and Company, Sydney, Australia; 2Emerging Markets Business Unit (Neuroscience), Eli Lilly and Company, Budapest, Hungary; 3E
Externí odkaz:
https://doaj.org/article/35000538854c42c9833f9617a87801b3
Autor:
Treuer, T., Tohen, M.
Publikováno v:
In European Psychiatry 2010 25(6):328-333
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.